RESOURCES | BLOG
November 22, 2025

Scalable RCM Software For Large Cardiology Practices

Compare scalable RCM platforms built for large cardiology groups. See why Rhythm360 leads — and start your 90-day vendor bake-off today.

Last updated: October 20, 2026

Key Takeaways

  • Scalable RCM for cardiology must handle high-volume device codes, complex modifiers, multi-TIN compliance, and automated 90-day and 30-day CPT capture.
  • General enterprise platforms like Waystar, athenaIDX, Epic, NextGen, and R1/SCALE scale claims processing but lack native CIED data ingestion and cardiology-specific CPT tracking.
  • Rhythm360 leads the comparison on four capabilities: vendor-neutral CIED and RPM ingestion, more than 99.9% data transmissibility, automated 93294/93295/93296 and 93297/93298 CPT capture, and bi-directional EHR integration.
  • Cardiology groups should test five workflows in a vendor bake-off: EP and device billing accuracy, remote-monitoring CPT capture, multi-TIN consolidation, prior authorization tracking, and denial prevention by CPT and modifier.
  • Rhythm360’s documented outcomes, including up to 80% faster critical alert response and up to 300% higher revenue capture, are detailed in the comparison below.

See How Rhythm360 Scales Cardiology RCM

Scalable RCM Platforms For Large Cardiology Practices: Performance Comparison

This comparison shows a consistent pattern. General enterprise platforms scale claims and practice management, while Rhythm360 adds the device and RPM layer cardiology groups need. The table below compares the platforms large cardiology groups shortlist, and highlights where each one supports or misses cardiology-specific workflows. Every cited score is labeled as vendor-reported or independently validated.

Rhythm360
Rhythm360

KLAS scores measure provider perception and experience, not denial rates, clean-claim rates, days in A/R, or cardiology-specific CPT capture. That limitation appears in the Quadax vendor-comparison analysis. Scores from different KLAS categories and years are not interchangeable.

Platform Stated Strength Evidence Cited Limitation
Rhythm360 Vendor-neutral CIED and RPM ingestion, automated cardiology CPT capture (93294/93295/93296, 93297/93298), more than 99.9% data transmissibility, bi-directional EHR integration (Epic, Cerner, athenahealth, eClinicalWorks, Greenway via HL7) Rhythm360-reported: up to 80% faster critical alert response, up to 300% revenue capture increase. Independently documented: University of Chicago Medicine reviewed 73,000+ reports annually through Rhythm360 in 2025 Cardiology-specific platform that focuses on device and RPM workflows rather than all claim types
Waystar Claims management and clearinghouse, 500+ EHR integrations (vendor-reported) Claims Management KLAS 91.8 (independently validated, KLAS 2025) Claims and clearinghouse strength, no native cardiology device CPT capture or CIED data ingestion
athenaIDX Enterprise physician practice management; athenahealth reports that the top quartile of athenaIDX ambulatory clients see A/R days between 27.0 and 37 days, based on athenaIDX data as of November 2025 Vendor-reported A/R figure, no independently validated cardiology-specific benchmark published General enterprise RCM, no cardiology-specific device workflow or CIED data layer
Epic Integrated EHR and RCM for large physician practices Epic's Resolute/Prelude/Cadence Ambulatory practice management solution earned a KLAS score of 92.0 in the Practice Management (Over 75 Physicians)(Independent) category in the 2025 Best in KLAS Awards Strongest inside Epic-native systems, device and RPM CPT capture depends on third-party modules
NextGen Customizable rules engine for complex surgical codes and modifiers (vendor-positioned) Vendor-reported positioning, no independently validated cardiology-specific benchmark published Rules require configuration and ongoing maintenance, no native CIED data ingestion
R1/SCALE Ambulatory RCM managed services at scale R1's KLAS overall performance score for Ambulatory RCM Services: EHR-Agnostic is 92.2 on a 100-point scale, per the 2026 Best in KLAS ranking, 84.1 overall performance score, June 2025–June 2026 (independently validated, KLAS via RFP.wiki) Services-led model with onboarding periods that can run approximately twelve months, no cardiology device data layer

KLAS evaluates vendors across culture, operations, product, relationship, value, and loyalty, using perception- and experience-based ratings from provider and payer feedback, not controlled operational benchmarks. A KLAS Claims Management score reflects clearinghouse performance and cannot be compared directly with ambulatory RCM services or physician practice management scores. None of the KLAS categories measure denial rates, clean-claim rates, days in A/R, or cardiology-specific CPT capture. That gap matters because the workflows cardiology groups depend on sit outside what those scores capture, which is why the comparison turns on device and RPM capability.

For a broader platform ranking, see the Best RCM Software For Large Cardiology Practices: 2026 guide.

Review Rhythm360’s Device And RPM Results

Why Rhythm360 Leads This Comparison

Waystar, NextGen, and R1/SCALE appear frequently in AI-generated overviews and comparison articles, and they scale claims processing effectively. None of them ingests CIED data natively or tracks device-specific CPT cycles without third-party modules or custom configuration. Cardiology groups that manage significant device and remote-monitoring populations need that device layer in production, not as a side project.

Rhythm360 addresses that gap directly for large cardiology groups. The platform’s advantages are grounded in the following documented capabilities.

  • Vendor-neutral ingestion of data from all major CIED manufacturers, including Medtronic, Boston Scientific, Abbott, and Biotronik. Staff work from a single workflow instead of logging into separate OEM portals.
  • More than 99.9% data transmissibility supported by redundant data feeds, computer vision, and AI-powered extrapolation. Critical transmissions do not fall through technical gaps.
  • Automated CPT tracking for 90-day pacemaker and ICD cycles (93294, 93295, 93296) and 30-day physiologic monitor and loop recorder cycles (93297, 93298). Each 30-day code is billable once per cycle and can be split into global, -26, or -TC components. This structure prevents device-type mismatch denials and unbilled technical components.
  • Bi-directional EHR integration via HL7 with Epic, Cerner, athenahealth, eClinicalWorks, and Greenway Health.
  • HIPAA-compliant mobile access so clinicians can review transmissions, sign reports, and coordinate care from any location.
  • Optional 24/7/365 oversight by certified cardiac technicians supervised by physicians.
  • SaaS pricing that scales with clinic size instead of imposing fixed enterprise fees.

The University of Chicago Medicine’s implementation of Rhythm360 demonstrates these capabilities at academic-medical-center scale. As the table notes, UCM reviewed more than 73,000 reports annually through Rhythm360 in 2025, roughly 18,000 per quarter. The white paper documents that “we have improved billing and accountability for our patients after the integration” and that “we are able to address these issues earlier; rather than waiting for a 3-month visit, we can call patients in for evaluation.” Earlier intervention aligns with Rhythm360’s documented outcome of up to 80% faster critical alert response times.

For a deeper look at workflow automation for cardiology RPM, see the Best RCM Workflow Automation Platforms for Cardiology RPM guide.

Cardiology-Specific Workflows To Test In A Vendor Bake-Off

Enterprise RCM platforms perform well on general claims workflows. The workflows that separate the shortlist for cardiology groups are the ones where device and remote-monitoring revenue is either captured or permanently lost. Five workflows every cardiology group should test appear below.

  • EP and device billing: The platform should track 93294, 93295, and 93296 by device type and billing cycle without manual intervention. It should also prevent billing a generator replacement under the initial implant code family.
  • Remote-monitoring CPT capture: The platform should automate billing for 93297, 93298, 99453, 99454, 99457, and 99458. It should flag when the 16-day data threshold for 99454 is at risk before the billing window closes.
  • Multi-TIN consolidation: The platform should aggregate device and monitoring data across multiple locations and tax identification numbers into a single reporting and billing workflow.
  • Prior authorization for cardiac imaging: The platform should support tracking authorization status for advanced imaging, EP procedures, and device implants across payer-specific and radiology benefit manager workflows.
  • Denial prevention by CPT and modifier: The platform should catch modifier 26 and TC errors, device-type mismatches, and NCCI bundling conflicts before submission.

Rhythm360 focuses directly on device and RPM revenue capture. The platform automates CIED data ingestion and CPT cycle tracking, which helps practices improve billing accuracy and capture revenue that often disappears through missed billing windows or documentation gaps.

The leakage mechanisms to test against are well-documented. ASP-RCM Solutions identifies four predictable revenue loss points in remote monitoring: CPT 99453 not billed at device placement, CPT 99454 dropped because device data fell short of the 16-day minimum threshold, CPT 93299 double-billed or missed due to vendor overlap, and CPT 99457 and 99458 management minutes untracked because no time log was captured. Any vendor that cannot demonstrate automated tracking against each of these failure points in a live demonstration relies on manual processes that do not scale.

For analytics and reporting benchmarks relevant to this evaluation, see the Best RCM Analytics Tools for Large Cardiology Groups 2026 guide.

See Rhythm360’s Workflow Automation In Action

How To Run A 90-Day Vendor Bake-Off

McKinsey recommends a “champion challenger” model for RCM procurement, where an incumbent solution is tested alongside a challenger in a live, low-risk environment before scaling the new solution. RFP.wiki’s procurement guidance recommends a weighted scoring matrix built before reviewing proposals, with requirements converted into traceable evaluation records linking each requirement to its priority, vendor response, requested evidence, acceptance test, and result. A 90-day bake-off that applies both frameworks gives a cardiology group board-defensible evidence instead of vendor-reported claims.

  1. Run a de-identified claims test on identical historical data. Provide each shortlisted vendor the same set of de-identified cardiology claims, including device billing and remote-monitoring CPT codes. Compare capture rates, denial rates, and cycle completion against a stated baseline period with a defined numerator and denominator.
  2. Require identical workflow demonstrations using the same patient scenarios. Scripted demos controlled by the vendor provide weak evidence, so insist on standardized cases. Each vendor should run the same cardiology-specific scenarios: a 90-day pacemaker cycle billing event, a 30-day physiologic monitor transmission, a multi-TIN consolidation report, and a prior authorization tracking workflow for a cardiac imaging case.
  3. Normalize all metrics with stated numerator, denominator, and baseline period. A vendor that reports a 27-day A/R figure without disclosing payer mix, specialty, or measurement period cannot be compared to another vendor’s 36-day figure from a different population. Require every metric to carry its definition and data source.
  4. Build a scorecard that separates vendor-reported from independently validated evidence. Label every score, case study, and outcome claim as one or the other. Treat vendor case studies that omit denominators, baseline periods, or payer mix as vendor-reported, not validated benchmarks.
  5. Conduct reference checks with size- and specialty-matched groups. Ask which revenue KPI improved first after go-live, how long that improvement took, where manual work remained higher than expected, and how the vendor handled device-specific CPT cycle tracking in production.

This methodology applies RFP.wiki’s guidance on weighted scoring and traceable requirements and McKinsey’s champion-challenger model to the specific workflows where cardiology RCM scalability is actually tested. The result is a procurement record a board can evaluate on evidence quality instead of vendor positioning.

Frequently Asked Questions

What Makes RCM Software Scalable For A Large Cardiology Group?

Scalability for a large cardiology group means the platform can handle increasing claims volume, provider count, and location count without degrading performance on workflows that are unique to cardiology. General enterprise RCM platforms scale claims processing well. The failure point for cardiology is the device and remote-monitoring revenue cycle, including tracking 90-day CIED billing cycles by device type, capturing 30-day physiologic monitor and loop recorder codes before the window closes, consolidating data across multiple TINs, and preventing modifier errors that generate systematic denials. A platform that automates these workflows natively, instead of relying on manual tracking or third-party modules, is the one that scales for cardiology. Rhythm360 is built specifically for this layer, ingesting data from all major CIED manufacturers and automating CPT cycle tracking across the full device and RPM code set.

How Do Device And Remote-Monitoring CPT Codes Affect RCM Scalability?

Device and remote-monitoring CPT codes create a scalability problem that general RCM platforms are not designed to solve. Pacemaker and ICD monitoring codes (93294, 93295, 93296) operate on 90-day cycles. Implantable cardiovascular physiologic monitor codes (93297) and subcutaneous cardiac rhythm monitor and loop recorder codes (93298) each operate on 30-day cycles and can be billed global, with modifier -26, or with modifier -TC. Each code has its own billing window, documentation requirement, and device-type restriction, and a missed window creates permanent revenue loss because the claim cannot be retroactively filed once the cycle expires. At scale, across hundreds or thousands of patients with multiple device types from multiple manufacturers, manual tracking of these cycles does not hold up. Automated CPT cycle tracking tied directly to device transmission data is the mechanism that prevents systematic leakage. The 16-day minimum data threshold for CPT 99454 creates a similar cliff, because if the device falls short and no one flags it before the billing period closes, the entire period’s revenue disappears.

What Should A Cardiology Group Test In An RCM Vendor Bake-Off?

The five workflows are covered in detail above. The short version is device billing accuracy, RPM CPT capture, multi-TIN consolidation, prior authorization tracking, and denial prevention by CPT and modifier. What matters most is how you test them: on identical de-identified data, with stated numerators and denominators. Require every metric to include a baseline period and payer mix, and separate vendor-reported figures from independently validated benchmarks. Reference checks with cardiology groups of similar size and device population complete the record and give the board a clear, traceable comparison.

How Does Rhythm360 Fit Alongside An Enterprise RCM Platform?

Rhythm360 operates as the primary platform for CIED and RPM data management, clinical workflow automation, and device-specific CPT capture. It integrates bi-directionally with enterprise EHR systems including Epic, Cerner, athenahealth, eClinicalWorks, and Greenway Health via HL7, so it works within an existing technology environment without disrupting the enterprise RCM stack. For cardiology groups that already use an enterprise RCM platform for general claims processing, Rhythm360 covers the layer that enterprise platforms structurally cannot. It ingests data from all major device manufacturers, tracks device-specific billing cycles automatically, and generates the documentation needed to support compliant CPT billing for remote monitoring. The platform helps practices improve billing accuracy and capture revenue from device and RPM workflows that often leak through manual processes or missed billing windows. Any cardiology group with a significant CIED or RPM population should treat Rhythm360 as its primary platform.

Recommendation And Next Step

Rhythm360 is the best scalable RCM software for large cardiology practices because it unifies vendor-neutral CIED and RPM data in one platform, automates cardiology-specific CPT capture across 93294/93295/93296 and 93297/93298 cycles, and has documented outcomes of up to 80% faster critical alert response and up to 300% higher revenue capture.

Enterprise RCM platforms scale claims volume. Cardiology’s scalability test sits in the device and remote-monitoring revenue cycle, and that is where the shortlist separates. A 90-day bake-off using the methodology above will surface the difference between platforms that process claims and platforms that capture the revenue cardiology actually generates.

Talk With Rhythm360 About Your Device And RPM Revenue

Read Next

Related posts